<DOC>
	<DOCNO>NCT00952276</DOCNO>
	<brief_summary>The purpose study evaluate different dos Influenza A/H1N1 pandemic vaccine adult elderly . Primary Objectives : - To describe immunogenicity candidate vaccine single injection . - To describe safety candidate vaccine single injection .</brief_summary>
	<brief_title>A Study Different Formulations Adjuvanted A/H1N1 Pandemic Vaccine Healthy Adults Elderly</brief_title>
	<detailed_description>Participants receive single injection randomize vaccine Day 0 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Healthy adult age 18 year old day inclusion Informed consent sign date Able attend schedule visit comply trial procedure For woman childbearing potential , use effective method contraception abstinence least 4 week prior first vaccination , least 4 week last vaccination . Exclusion Criteria : Known pregnancy positive urine pregnancy test Currently breastfeed child Participation another clinical trial investigate vaccine , drug , medical device , medical procedure 4 week precede first trial vaccination Planned participation another clinical trial present trial period Receipt vaccine 4 week precede trial vaccination , except inactivate seasonal influenza vaccine , within two week precede trial vaccination Planned receipt vaccine prior Day 42 blood sample Receipt blood bloodderived product past 3 month might interfere assessment immune response Known suspect congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) Selfreported seropositivity Human Immunodeficiency Virus ( HIV ) , Hepatitis B antigen , Hepatitis C Known systemic hypersensitivity vaccine component , history lifethreatening reaction vaccine ( ) use trial vaccine contain substance Self report thrombocytopenia contraindicating intramuscular ( IM ) vaccination Bleeding disorder receipt anticoagulants 3 week precede inclusion contraindicate IM vaccination Deprived freedom administrative court order , emergency setting , hospitalize involuntarily Current alcohol abuse drug addiction may interfere subject 's ability comply trial procedure Chronic illness opinion Investigator , stage might interfere trial conduct completion Employees Investigator study center , direct involvement propose study study direction Investigator study center , well family member employee Investigator Previous participation swineorigin A/H1N1 pandemic flu trial except performed 1976 Any confirm case influenza ( include swineorigin A/H1N1 Influenza ) since March 2009 Febrile illness ( temperature ≥ 100.4°F [ ≥ 38.0°C ] ) moderate severe acute illness/infection ( accord Investigator judgment ) day vaccination Personal family history GuillainBarré syndrome Active neoplastic disease history hematologic malignancy Known seizure/epilepsy history and/or take antiseizure medication Receipt psychiatric drug . Subjects receive single antidepressant drug stable least 3 month prior enrollment , without decompensating symptom allow enroll study Any Grade 1 , 2 , 3 liver function value ( Alanine aminotransferase ( ALT ) , Aspartate aminotransferase ( AST ) , Alkaline phosphatase ) observe blood sample take Screening Any Grade 2 Grade 3 laboratory abnormality blood sample take Screening Receipt monovalent 2009 pandemic H1N1 vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Influenza Pandemic Flu Swine-origin A/H1N1 Influenza Adults</keyword>
</DOC>